1 3 5 0 VOLUME 48 | NUMBER 11 | NOVEMBER 2016 Nature GeNetics A r t i c l e s for about 50% of bilateral PNH and the associated Ehler-Danlos conditions affecting mostly females 7 . Compelling studies suggested that FLNA-related PNH results from the combination of defects affecting the polarized radial glia scaffold and its adhesion to the neuroependymal membrane, neural progenitor proliferation and neuronal migration [8] [9] [10] . Other mechanisms contributing to PNH development were proposed following the identification of rare familial forms of PNH associated with recessive mutations in ARFGEF2, which encodes the ADP-ribosylation factor guanine exchange factor 2 (GEF2) 11 . Finally, other genetic forms of PNH have been mapped through array comparative genomic hybridization (aCGH) studies, but only one potential causal gene, C6orf70 (ERMARD) located at 6q27, has been identified 12 .
Here we provide evidence implicating the E3 ubiquitin ligase gene NEDD4L in the development of PNH. We report the identification of missense mutations in NEDD4L in patients with PNH, bilateral syndactyly, cleft palate and neurodevelopmental delay. We further show that PNH-related NEDD4L mutants disrupt neurodevelopmental processes, likely through dysregulation of the mTOR and AKT signaling pathways.
RESULTS

Patients with PNH analyzed by whole-exome sequencing and mutations in NEDD4L
We used clinical and brain magnetic resonance imaging (MRI) data from patients with MCD referred for genetic investigations and selected 15 patient-parent trios for analysis by whole-exome sequencing. All families had a single affected patient with bilateral PNH.
For the whole-exome sequencing approach, we applied a previously described experimental workflow to detect and prioritize sequence variants and validate significant findings 13, 14 . We then analyzed filtered exome data and searched for recurrence of de novo mutations in the same gene in unrelated patients. We identified de novo missense changes in NEDD4L in two patients with bilateral contiguous PNH, bilateral syndactyly of the second and third toes, and neurodevelopmental delay (P158 and BRC217; Fig. 1a,b , Table 1 and Supplementary Note). After validation of the mutations by Sanger sequencing (Supplementary Fig. 1a,b) , we screened NEDD4L (coding exons and their flanking sequences) in a cohort of 96 patients with MCD and identified the c.2677G>A mutation (already detected in BRC217) in one additional patient (P347; Fig. 1c , Table 1 and Supplementary Fig. 1c) . Interestingly, the phenotype of this patient was also characterized by bilateral PNH, bilateral syndactyly of the second and third toes, and neurodevelopmental delay ( Table 1 and Supplementary Note). As the family of patient P347 consisted of two affected children (P347 and her brother), a healthy girl and healthy parents ( Supplementary Fig. 1c) , we tested the segregation of the variant in all members of the family. We found the variant to be present in a heterozygous state in the affected brother but absent from the DNA of the healthy sister and father. For the mother, however, sequencing traces consistently showed an imbalance in the height of the peaks corresponding to normal and variant alleles ( Supplementary Fig. 1c ). Altogether, these results were suggestive of germline and somatic mosaicism of a NEDD4L variant in the mother. To confirm this and evaluate the level of somatic mosaicism, we analyzed the mother's DNA by digital droplet PCR and found that the frequency of the Figure 1 Mutations in NEDD4L cause PNH and syndactyly. (a-e) Photographs and representative sections of brain MRIs for affected individuals illustrating frequent toe syndactyly and constant PNH. For each patient, two axial sections, or one axial and one coronal section, show confluent nodules of heterotopia lining the lateral ventricles (arrowheads). Sagittal sections show thin (c) or dysmorphic (a and c, II-3) corpus callosum. In d, in addition to PNH (arrowheads), the MRI section shows frontal PMG (white arrows). MRIs were performed at the age of 8 years (a), 12 months (b), 9 and 12 months (c), 7 months (d) and 8 months (e). MRIs were not available for patient Pnh31124 with the c.2082G>T; p.Gln694His mutation. Written consent was obtained to publish patient photographs. (f) Linear representation of the NEDD4L polypeptide showing the positions in the HECT domain of the heterozygous PNH-associated mutations. NEDD4L protein is characterized by an N-terminal C2 domain known to bind Ca 2+ and phospholipids 17 , two to four WW protein-protein interaction domains 16 responsible for recognition of the substrate, and the C-terminal catalytic HECT domain 18 . mutated allele was around 16% ( Supplementary Table 1 ). In view of these molecular data, the mother was reexamined and neurological, cognitive and behavioral evaluations were found to be normal.
Shortly after these initial findings, we reinforced the implication of NEDD4L by the identification of additional de novo mutations in three unrelated patients with PNH ( Table 1 ). The first patient (PNC: Fig. 1d , Table 1 and Supplementary Fig. 1d ) was identified through targeted screening of an MCD-related panel of genes in which we included NEDD4L. The second and third patients-DDDP110533 ( Fig. 1e , Table 1 and Supplementary Fig. 1e ) and Pnh31124 ( Table 1 and Supplementary Fig. 1f )-were identified through data sharing of trios exome sequenced and analyzed as part of the Deciphering Developmental Disorders and Epi4K Consortium studies. For all three patients, brain MRI results also showed the presence of PNH associated with syndactyly and neurodevelopmental delay ( Fig. 1d,e , Table 1 and Supplementary Note).
NEDD4L 15 (also known as NEDD4-2) encodes a member of the NEDD4 family of HECT-type E3 ubiquitin ligases known to regulate the turnover and function of a number of proteins involved in fundamental cellular pathways and processes [16] [17] [18] [19] . Interestingly, all mutations associated with PNH mapped to the HECT domain ( Fig. 1f) , and relevance of their pathogenic effect was suggested by the high degree of conservation of the affected residues ( Supplementary Fig. 2a ), bioinformatics predictions (from the MutationTester tool) and structural modeling of the HECT domain ( Supplementary Fig. 2b-j) .
Functional effects of wild-type NEDD4L and NEDD4L mutants
We first analyzed the expression of Nedd4l during mouse brain development. As illustrated in Supplementary Figure 3a (in situ hybridization at embryonic day (E) 15), Nedd4l transcripts were homogenously distributed in the cortical plate, ventricular zone and ganglionic eminences. Moreover, analysis of Nedd4l expression by real-time qPCR in developing mouse cortex from E12.5 to E18.5 showed a peak of expression at E16.5 ( Supplementary Fig. 3b ), a developmental stage characterized by both proliferation and migration.
To assess the cellular consequences of PNH-related mutations, we transfected N2A cells with cDNA constructs for wild-type NEDD4L and three different mutants and compared expression levels and localization by immunofluorescence ( Fig. 2) . We found that wild-type NEDD4L was highly expressed ( Fig. 2a and Supplementary Fig. 4 ), and its localization was in line with what was previously reported 20 . In contrast, PNH-related mutant proteins were hardly detectable. Indeed, 48 h after transfection, we only detected a faint signal, comparable to the background signal of cells transfected with control empty vector ( Fig. 2a) . Similar results were observed upon transfection of primary cultured mouse neurons ( Supplementary Fig. 4 ). We also confirmed the lack of mutant NEDD4L expression by immunoblotting using protein extracts from transfected N2A cells (Fig. 2b) . In view of these results, we hypothesized that PNH-associated mutants are unstable and examined NEDD4L protein expression in transfected cells treated with the proteasome inhibitor MG132. We observed by immunofluorescence and immunoblot experiments high levels of expression of PNH-related NEDD4L mutants ( Fig. 2a,b) .
To further ascertain that the instability of NEDD4L mutant proteins represents a disease-relevant phenotype, we tested the expression of three control variants reported in the ClinVar and/or Exome Aggregation Consortium (ExAC) databases. Referring to NM_001144967, these variants are c.698C>T, p.Ser233Leu; c.535T>A, p.Ser179Thr and c.2614G>A, p.Gly872Ser (located in the HECT domain). Cellular localization and expression levels for the different control versions of NEDD4L constructs were similar to those of wild-type NEDD4L ( Supplementary Fig. 5a,b) .
To strengthen the implication of a post-transcriptional mechanism, we analyzed the expression of NEDD4L transcripts by qRT-PCR using A r t i c l e s cotransfected reporter GFP as a normalizer. We found that wild-type NEDD4L transcript levels were approximately 1.5-to 2-fold higher than mutant levels ( Supplementary Fig. 6 ), a range of difference that does not explain the almost complete absence of the mutant proteins. Because all the mutations map to the catalytic HECT domain of the NEDD4L E3 ligase and lead to protein instability, we sought to assess the consequences of disease-causing variants for enzymatic activity and self-ubiquitination. To this end, we focused on the Arg897Gln mutant and compared by two different approaches the ubiquitination ability of wild-type NEDD4L and the mutant.
First, to test specifically for NEDD4L ubiquitination, we transfected N2A cells with cDNA constructs encoding N-terminally V5-tagged NEDD4L, immunoprecipitated NEDD4L from lysates using antibody to V5 and immunoblotted with an antibody to ubiquitin to detect conjugation of ubiquitin. Long exposure times for the immunoblots showed a high-molecular-mass smear mainly representing selfubiquitinated wild-type and mutant NEDD4L. Interestingly, despite the instability of the V5-tagged mutant protein and its low amount, the intensity of the smear detected by antibody to ubiquitin was comparable to that for the wild-type protein (Supplementary Fig. 7a ). Figure 2 Expression and cellular localization of wild-type and mutant NEDD4L. (a) Tomato/DAPI and NEDD4L detection in N2A cells transfected with empty vector or cDNA constructs encoding wild-type (WT) or mutant NEDD4L. For each construct, cultured cells were treated with either DMSO or MG132. NEDD4L immunostaining shows a cytoplasmic distribution with enrichment in the periphery of N2A cells for wild-type NEDD4L, whereas the Gln694His, Glu893Lys and Arg897Gln mutants are not detectable. Scale bar, 50 µm. (b) Immunoblots using protein extracts from N2A cells transfected with constructs encoding wild-type and mutant NEDD4L and cultured in the presence of either DMSO or MG132. Blots show lack of expression of PNH-associated mutants, while transfection for wild-type NEDD4L led to a high level of expression for NEDD4L protein. Note that PNH-associated NEDD4L mutants become detectable upon treatment of N2A cells with MG132.
Second, we compared the ubiquitination ability of immunopurified V5-tagged NEDD4L (wild type and mutant) in an in vitro assay using recombinant E1 and E2 (UbcH7) enzymes with or without ubiquitin. In the presence of ubiquitin, both wild-type and mutant NEDD4L exhibited ubiquitination activity as illustrated by the high-molecular-mass smear detected by antibody to NEDD4L (Supplementary Fig. 7b ).
To further confirm and better visualize the ubiquitination activity of the NEDD4L mutant, we performed another series of immunoprecipitation and in vitro assays and immunoblot analysis in which we loaded four times less protein products to the assay with wild-type NEDD4L than to the one with mutant NEDD4L (Fig. 3) . Although accurate comparison of wild-type and mutant NEDD4L ubiquitination activities is difficult, both immunoprecipitation ( Fig. 3a) and in vitro ubiquitination (Fig. 3b ) approaches showed that mutant NEDD4L induced a high-molecular-mass smear detected with antibodies to V5 and NEDD4L.
These results suggest that the ubiquitination activity of mutant NEDD4L is preserved and possibly enhanced if we take into account the substantial level of ubiquitination activity despite the instability of the protein.
At first sight, the fact that PNH-related NEDD4L mutants are unstable led us to consider a haploinsufficiency mechanism. However, previously reported findings and our data made this hypothesis questionable. For instance, postmitotic neurons deficient for both Nedd4-1 and Nedd4l (analyzed in conditional double-knockout mice) migrate properly to the cortical plate 21 . Also, neuronal migration disorders and PNH are not among the features associated with haploinsufficiency resulting from heterozygous copy number variations (CNVs) reported in DECIPHER databases. Moreover, one stop-gain and three frameshift mutations were reported in the ExAC data set from which individuals affected by severe pediatric disease have been excluded. Finally, we used an in utero RNA interference Figure 3 Ubiquitination activity of mutant NEDD4L. (a) Immunoprecipitation assay (IP; using antibody to V5 to precipitate tagged NEDD4L), with precipitates analyzed by immunoblot (IB) using antibodies to ubiquitin and V5 to detect ubiquitinated NEDD4L (FT, flow through). (b) Analysis of NEDD4L ubiquitination activity in an in vitro assay using wild-type and mutant NEDD4L immunopurified from the lysates of transfected N2A cells and incubated with ATP, E1 enzyme and E2 (UbcH7) enzyme with (+) or without (−) ubiquitin (Ub). Reaction mixtures were analyzed by immunoblotting with antibodies to V5 and NEDD4L. Note that, because of the instability of mutant NEDD4L and the resulting imbalance in the amounts of wild-type and mutant NEDD4L and corresponding immunoblot signals, as shown in supplementary Figure 7 , immunoblot analysis was performed using four times less reaction mixture for wild-type NEDD4L than for mutant NEDD4L. A r t i c l e s approach to analyze the consequences of Nedd4l downregulation on cortical neuronal migration in mice and found no significant difference between embryo brains transfected with short hairpin RNA (shRNA) targeting Nedd4l and scrambled shRNA control ( Supplementary Fig. 8a,b) .
In view of these convergent arguments, we then sought to study the consequences of PNH-related mutations for neurodevelopmental processes. We used an in utero electroporation (IUEP) approach and compared the consequences of expression of wild-type NEDD4L and mutants (Glu893Lys and Arg897Gln) for neuronal positioning, neuronal progenitor proliferation and terminal translocation. To assess effects on projection neuron positioning, we electroporated NEDD4L constructs in combination with Tomato reporter construct into progenitor cells located in the ventricular zone of E14.5 mouse neocortices and analyzed embryo brains 4 d later (E18.5). In E18.5 brain sections, we observed that neurons electroporated with the empty vector reached the cortical plate (Fig. 4a,b) . However, IUEP of wild-type NEDD4L and PNH-related mutants induced significant arrest of cells within the ventricular zone and subventricular zone and intermediate zone with corresponding depletion in the cortical plate ( Fig. 4a,b) . We also assessed the effect on neuron positioning at postnatal day (P) 2 and highlighted differences that paralleled those observed at E18.5. Whereas neurons electroporated with empty vector were mainly located in superficial layers II-IV of the cortical plate, we found that neurons electroporated with constructs for wild-type NEDD4L and PNH-related mutants were abnormally distributed in the white matter and in layers V and VI of the cortical plate ( Supplementary Fig. 9a,b) .
As our cellular data suggested that PNH-related NEDD4L mutants are unstable, we also assessed whether the same effect could be observed in vivo in electroporated migrating neuronal cells. We found that cells electroporated with construct for wild-type NEDD4L exhibited strong cytoplasmic immunolabeling ( Fig. 4c and Supplementary  Fig. 9c ), consistent with a high level of NEDD4L expression. However, in neurons electroporated with mutant constructs, we only detected a faint signal that could correspond to endogenously expressed NEDD4L ( Fig. 4c and Supplementary Fig. 9c ).
To study terminal translocation [22] [23] [24] [25] , we conducted IUEP of the different constructs at E14.5 and collected brains 6 d later (P2) from the pups. We then assessed the distribution of electroporated neurons with a leading process adhering to the extracellular matrix (ECM) in the region previously defined as the primitive cortical zone (PCZ) 24 , and in the upper and lower Cux1 regions corresponding to two equal parts of the remaining Cux1-positive layer (Supplementary Fig. 10 ). We found that expression of wild-type and mutant NEDD4L led to an abnormal distribution of neuronal cells with a deviating enrichment in the lower Cux1 region (Supplementary Fig. 10 ), suggesting that terminal translocation was disrupted.
To test the consequences of the NEDD4L mutations on apical and basal progenitor proliferation, we performed IUEP at E14.5 and collected embryos 48 h later for immunohistochemistry using antibodies against PH3, Pax6, Tbr2 and Ki67. We found a significantly higher percentage of Tomato-positive and PH3-positive co-labeled cells expressing wild-type protein or HECT-domain mutants in the ventricular zone when compared to Tomato-positive cells expressing the control empty vector ( Fig. 4d and Supplementary Fig. 9d) . These results suggested an increased mitotic index of apical progenitors electroporated with wild-type NEDD4L and PNH-related mutants. We also quantified electroporated Pax6-positive and Tbr2-positive cells in the ventricular zone and subventricular zone and found an increased number of these cell populations only in brains electroporated with PNH-related mutant constructs ( Fig. 4e and Supplementary Fig. 9e) .
To assess the pool of proliferating cells, we evaluated cells positive for both Tomato and Ki67 in the ventricular zone and subventricular zone; in both regions, we did not observe any differences following electroporation with control empty vector and cDNA constructs encoding wild-type and mutant NEDD4L ( Supplementary Fig. 9f,g) .
We also performed immunohistochemistry against the Cux1 marker at E18.5 and observed that arrested neurons electroporated with wild-type NEDD4L or PNH-related mutants expressed Cux1, indicating that misplaced neurons in deep layers of the cortex are differentiated and fated for upper layers (Supplementary Fig. 9h ).
Finally, we labeled brain slices (E16.5 and E18.5) with antibody to cleaved caspase-3 to evaluate cell death rate and found no difference following electroporation with the different constructs (data not shown).
Pathways disrupted by wild-type and mutant NEDD4L causing PNH
Although the best known target of NEDD4L is the epithelial sodium channel (ENaC), shown to be involved in Liddle syndrome, a hereditary hypertension caused by elevated ENaC activity 26 , compelling evidence demonstrating crucial regulatory roles of NEDD4L in developmental processes has recently emerged 19, 27 . In this study, we sought to investigate the consequences of wild-type and mutant NEDD4L on mTOR-dependent pathways for the following main reasons. 
A r t i c l e s
First, in view of the association of MCD and distal-limb abnormalities observed in patients described in this study, we wondered whether these developmental abnormalities represent a particular condition in the wide range of developmental brain and body disorders caused by dysfunctions of the interdependent phosphatidylinositol 3-kinase (PI3K)-AKT-mTOR pathways 5, 14 . Second, among the many identified signaling pathways that modulate neuronal migration, the recently reported insights linking neuronal migration deficit in tuberous sclerosis complex (TSC) pathology with a cascade involving mTOR signaling, E3 ubiquitin ligase Cul5 expression and Dab1 expression 28 also led us to consider a potential effect of NEDD4L on mTOR and Dab1 signaling pathways. Third, NEDD4L was recently identified as a critical player in regulation of the crosstalk between PI3K-mTORC2 and TGF-β-activin-Smad2-Smad3 (Smad2/3) signaling pathways 29, 30 . Therefore, we first tested by cellular and immunoblot assays the effect of wild-type and mutant NEDD4L on mTORC1, Akt and Smad2/3 signaling activities. Following transfection of N2A cells with constructs for wild-type NEDD4L and PNH-associated mutants, we observed an increased level of phosphorylated S6 (Ser240/Ser244) that reflects elevated mTORC1 signaling activity (Fig. 5a,c) . In contrast, for Akt, only PNH-associated NEDD4L mutants were associated with significantly increased levels of Akt forms phosphorylated at Thr308 and Ser473 (Fig. 5b,c) .
To reinforce the relevance and specificity of NEDD4L mutant expression to the above highlighted findings, we tested the effect of the three control variants on S6 and Akt phosphorylation and found that overexpression of the three NEDD4L variants was associated with a phosphorylation pattern that was similar to the one with wild-type NEDD4L (Supplementary Fig. 5b) .
For Smad2/3 activity, we tested the effect of wild-type and Arg897Gln NEDD4L under the basal condition and upon activation of the TGF-β pathway by activin A on the expression levels of Smad2 phosphorylated at Ser465/Ser467, Smad3 phosphorylated at Ser423/ Ser425 and Akt phosphorylated at Ser473. Under the basal condition, we found that overexpression of wild-type NEDD4L had no effect on the activation level of Smad2/3, whereas expression of mutant NEDD4L was associated with a substantial increase in the levels of phosphorylated Smad2/3 (Supplementary Fig. 11) . Upon activation by activin A of the TGF-β pathway, we found that overexpression of wild-type NEDD4L was associated with an increase in the levels of phosphorylated Akt and Smad2/3, whereas expression of the NEDD4L mutant was associated with a substantial decrease in the levels of phosphorylated Akt and stable levels of phosphorylated Smad2/3 (Supplementary Fig. 11 ). Collectively, these results suggested that expression of the NEDD4L mutant leads to disruption of the regulated crosstalk between Akt and Smad2/3 signaling in activin-TGF-β pathways.
To assess the in vivo contributions of these pathways to the developmental defects described above, we used an IUEP approach in combination with treatment with rapamycin (a well-known mTORC1 inhibitor) on pregnant mice and analyzed the effect on projection neuron positioning. Interestingly, in E18.5 brain sections from embryos electroporated at E14.5 with wild-type NEDD4L and subjected to A r t i c l e s rapamycin treatment, we found clear rescue of the neuronal positioning defect with a distribution of electroporated cells across the cortex similar to what was observed in embryos electroporated with control empty vector (Fig. 6a,b) . For this latter condition, the distribution of neuronal cells with or without rapamycin treatment was similar (Fig. 6a,b) . However, rapamycin treatment induced only a partial rescue of the neuronal position defect resulting from IUEP with constructs for PNH-related mutants (Fig. 6a,b) . We found that the number of Tomato-positive neurons with delayed migration was reduced in the intermediate zone, while the number of neurons that reached the cortical plate was significantly increased (Fig. 6a,b) . We also analyzed the expression of NEDD4L in neuronal cells that reached the cortical plate after rapamycin treatment and found an absence of NEDD4L expression in neurons electroporated with constructs for PNH-associated mutants (data not shown), whereas neurons electroporated with construct for wild-type NEDD4L still expressed a high level of NEDD4L (Supplementary Fig. 12 ).
We then analyzed brain sections by immunohistochemistry using antibodies against Dab1 and assessed whether rapamycin-rescued neuronal position correlates with relevant changes in Dab1 expression and distribution in electroporated neurons. In arrested neuronal cells electroporated with construct for wild-type NEDD4L, we found striking labeling suggesting enrichment and nearly exclusive localization of Dab1 in the periphery of the cytoplasm, a distribution that is easily distinguishable from the diffuse pattern found in neurons electroporated with empty vector or mutant constructs (Fig. 6c) . Interestingly, following rapamycin treatment, in the predominant pool of neurons that reached the cortical plate and that still expressed a high level of wild-type NEDD4L, we found restoration of the diffuse pattern of Dab1 localization (Fig. 6c) . However, in neurons electroporated with constructs for PNH-associated mutants, no significant change in Dab1 cellular localization was observed, either in misplaced neurons or in the rescued neurons that reached the cortical plate (Fig. 6c) .
DISCUSSION
Our findings demonstrate the critical role of NEDD4L in the regulation of processes involved in cortex development and implicate mutations in the HECT domain of NEDD4L in PNH. We report the identification of one transmitted and five de novo mutations in seven patients (two siblings and five unrelated patients) with a common distinguishable phenotype characterized by PNH, intellectual disability, cleft palate and syndactyly (in six of seven patients). All mutations associated with this phenotype are located in the region of NEDD4L encoding the HECT domain of the E3 ubiquitin ligase NEDD4L, and one of these mutations, c.2677G>A, p.Glu893Lys, is a recurrent mutation that was found in three unrelated families ( Table 1) .
One of the intriguing effects of the PNH-related mutations was the likely increase in sensitivity of the corresponding mutants to proteasome degradation. To explain this sensitivity, we propose the hypothesis illustrated by the model in Figure 7a . Mutations causing amino acid changes in the HECT domain could lead to conformation changes and constitutive activation of catalytic function, which in turn could trigger autoubiquitination of NEDD4L mutant variants and their degradation. This hypothesis is based on previously reported studies suggesting that catalytic activity, including autoubiquitination of HECT E3 ligases, is dependent on NEDD4L conformation [31] [32] [33] [34] .
With the model of constitutive activation due to mutations in the HECT domain, one could expect not only autoubiquitination but also aberrant ubiquitination of other NEDD4L substrates, whereas a conventional loss-of-function mechanism is expected to lead to a deficit in ubiquitination activity. Moreover, despite autoubiquitination and degradation, the predicted state of constitutive activation for NEDD4L mutants could mimic the increased activity resulting from the overexpression of wild-type NEDD4L. This model could therefore reconcile, at least partially, the apparent discrepancy regarding the observed similar neurodevelopmental defects resulting from IUEP of stable wild-type NEDD4L and the unstable NEDD4L mutants.
Another finding that was observed with wild-type and mutant NEDD4L corresponds to a positioning defect of postmitotic neuronal cells. In the misplaced neuronal cells overexpressing wild-type NEDD4L, we observed a distinct pattern of Dab1 distribution. It is worth mentioning that this finding is in line with previously reported studies that demonstrated association between excess nucleocytoplasmic Dab1 in the cytoplasm of postmitotic neurons and its inhibitory effect on neuronal migration 35 . In arrested neuronal cells electroporated with NEDD4L mutants, the unchanged distribution of Dab1 suggests that the neuronal migration defect caused by NEDD4L mutants could be mediated by a mechanism divergent from the one disrupted by overexpression of wild-type NEDD4L. In favor of this view is evidence suggesting that excess wild-type NEDD4L is associated with the disruption of signaling pathways regulated by mTORC1 and Dab1. In contrast, PNH-related mutants might act through deregulation of mTORC1, Akt, mTORC2 and TGF-β-Smad2/3 pathway activities (Fig. 7b) . Although further investigations are required to define the exact mechanisms by which NEDD4L overexpression and variants affect these pathways, these hypotheses are supported by a recent study showing that NEDD4L catalyzes ubiquitination of PIK3CA and regulates PI3K-AKT signaling 35 and by our rapamycin-based experiments. Indeed, the consistent rescue of the neuronal position defect and restoration of the cellular distribution of Dab1 by rapamycin treatment suggest that the migration and positioning defects induced by overexpression of wild-type NEDD4L could be mediated by mTORC1 pathway deregulation. For PNH-related mutants, in addition to the increased activity of mTORC1, the deregulation of Akt and Smad2/3 activities under basal conditions and upon TGF-β activation provides an interesting entry point to understand further the role of NEDD4L in the regulation of neurodevelopmental processes underlying cortical development and the established implication of PI3K-AKT signaling pathways in a large spectrum of neurodevelopmental syndromes caused by activating mutations in AKT3, PIK3R2 and PIK3C, some of which are associated with phenotypic features of MCD 5, 14, 36, 37 .
As a whole and to the best of our knowledge, we have for the first time shown that mutations in NEDD4L altering the HECT domain are associated with PNH and that excess NEDD4L is likely to be deleterious for brain development and functioning. This latter finding therefore provides a basis for a better understanding of phenotypes associated with duplications encompassing NEDD4L. In this study, we also reported evidence highlighting the disruptive consequences of NEDD4L mutations on the AKT-mTOR and TGF-β-Smad2/3 signaling pathways. Moreover, our study identified a potential novel disease-causing molecular mechanism, in which missense mutations might lead to a constitutively active state and loss of the mutant protein, but with functional consequences that are different from constitutive haploinsufficiency. 
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ONLINE METHODS
Subjects, whole-exome sequencing and variant validation.
Blood or DNA samples from affected individuals and their parents and informed consent were obtained from all participants in accordance with site-specific institutional review boards. Written consent was obtained to publish patient photographs. For the selected 15 patients with PNH in association with developmental delay and/or epilepsy, 3 of the 15 patients also had PMG. For all patients, mutations in known PNH-related genes (FLNA, ARFGEF2 and C6orf70) and pathogenic copy number variations (CNVs) had previously been excluded. DNA processing, library generation, exome enrichment and whole-exome sequencing in trios comprising affected subjects and their parents were performed and data were analyzed at the French National Centre for Genotyping (CNG, Evry, France), the Paris Descartes Bioinformatics platform and the Sanger Sequencing Centre as previously described 13, 14, 38 . Available genomic databases (dbSNP, 1000 Genomes Project, Exome Variant Server, Exome Aggregation Consortium and a local Paris Descartes Bioinformatics platform database) were used to filter exome variants and exclude variants with a frequency greater than 1%. De novo variants were analyzed by PCR and direct Sanger sequencing using DNA from patients and their parents. In the family with two affected siblings and suspected maternal somatic mosaicism, confirmation and estimation of the percentage of cells bearing the variant was performed by the droplet digital PCR approach (QX100 Droplet Digital PCR System, Bio-Rad Life Science Research) using DNA extracted from the peripheral blood of all members of the family (the two patients, the parents and the unaffected individual) and primers specific to the variant and wild-type sequences. Data were analyzed with QuantaSoft v.1.4 software (Bio-Rad Life Science Research).
Protein modeling. Amino acid substitutions were plotted onto the solved protein structure for the catalytic domain of the human NEDD4-like E3 ligase using the Phyre web portal. Models were built by homology modeling using Research Collaboratory for Structural Bioinformatics Protein Data Bank (PDB) code 2ONI. The images in Supplementary Figure 2 were rendered using Chimera.
Cloning and plasmid constructs. Human untagged NEDD4L cDNA (NM_001144967.1) cloned into pCMV6-Entry vector (SC326303) was purchased from Origene. Mutations were introduced by site-directed mutagenesis using the QuikChange Site-Directed Mutagenesis kit (Agilent Technologies). Wild-type and mutated cDNAs encoding human NEDD4L were then inserted into the multiple-cloning site of psiSTRIKE vector under the control of the CAG promoter, pCDNA3-nV5. For IUEP experiments, psiSTRIKE-NEDD4L vectors were electroporated in combination with a pCAGGS-IRES-Tomato vector to visualize electroporated cells.
For RNA interference (RNAi) experiments, a 29-mer sequence targeting mouse Nedd4l mRNA and a HuSH 29-mer non-effective shRNA scrambled cassette, both commercially designed and provided by Origene in the p-GFP-V-RS vector (TG505433), were inserted into psiSTRIKE vector under the control of the U6 promoter. The Nedd4l shRNA directed against the coding sequence was checked for specificity in sequence databases. Because of the very low level of expression of NEDD4L, efficiency experiments were conducted using cotransfection with wild-type human NEDD4L cDNA and shRNA constructs in N2A cells and immunoblot analysis.
In situ hybridization. Mouse Nedd4l sense and antisense probes (nucleotides 462 to 1,470 of transcript NM_001114386) were synthesized using T7 RNA polymerase (Roche) from pJET2.1-Nedd4l (nucleotides 462 to 1,470) and pJET2.1-Nedd4l (nucleotides 1,470 to 462) plasmids. Non-radioactive RNA in situ hybridization on frozen brain sections was performed as previously described 39 .
qRT-PCR. Total RNA was prepared from the brains of mouse embryos at different time points of development and from cultured transfected cells with TRIzol reagent (Thermo Fisher Scientific), and cDNA samples were synthetized with SuperScript II Reverse Transcriptase (Invitrogen). qRT-PCR was performed in a LightCycler PCR instrument (Roche) using SYBR Green Master Mix (Roche). For transfection-based experiments, we used GFP as a normalizer (that is, systematically cotransfected as a reporter). For qRT-PCR of transcripts expressed from transfected cDNA constructs, RNA samples were treated with Turbo DNase (Ambion, Life Technology) to avoid amplification from plasmid DNA. Also, to ensure that we amplified transcripts expressed from transfected constructs, for each sample real-time qPCR (in triplicate) was performed using the cDNA reaction products obtained with or without reverse transcriptase and primers specific to NEDD4L and GFP.
Cell culture, transfections and immunofluorescence. Mouse neuroblastoma N2A cells were cultured in DMEM (Gibco) supplemented with 5% FCS and transfected using Lipofectamine 2000 (Invitrogen). MG132 (Calbiochem) was dissolved in DMSO solution buffer. DMSO was used as a control vehicle. Cells were treated with MG132 at a 10 µM concentration for 15 h before the end of culture. Expression of transfected genes was analyzed 48 h after transfection by immunocytochemistry and immunoblotting.
For primary cultures of neuronal cells, embryonic mouse cortical neurons (E17) were electroporated using the Amaxa mouse Nucleofector kit (Lonza) and maintained in Neurobasal medium supplemented with 2% B27, 1% glutamine and 1% penicillin-streptomycin. Cells were fixed in 4% paraformaldehyde 96 h after electroporation. Immunocytochemistry was performed according to standard procedures using antibody to Nedd4l (13690-1-AP, rabbit, Proteintech; 1:200 dilution) as the primary antibody and donkey antirabbit IgG 647 (A-21208, Life Technologies; 1:800 dilution) as the secondary antibody. Results were observed and photographed using a TCS SP5 confocal microscope (Leica Microsystems).
Immunoblotting. Cells were lysed in RIPA buffer (50 mM Tris-HCl, pH 7.7, 0.15 M NaCl, 1 mM EDTA and 1% Triton X-100) supplemented with protease inhibitors (Roche) and phosphatases inhibitors (Sigma-Aldrich). Protein concentration was measured using Bio-Rad protein assay reagent. Samples were denatured at 95 °C for 10 min in loading buffer and then resolved by SDS-PAGE and transferred onto nitrocellulose membranes. Membranes were blocked in 5% nonfat milk in TBS buffer with 0.1% Tween and then immunoblotted using the following primary antibodies at the specified concentrations: Nedd4l (13690-1-AP, rabbit, Proteintech; 1:1,000 dilution), actin (mouse, IGBMC; 1:1,000 dilution), Akt-pSer473 (4060, rabbit, Cell Signaling Technology; 1:1,000 dilution), Akt-pThr308 (2965, rabbit, Cell Signaling Technology; 1:1,000 dilution), Akt (pan) (4691, rabbit, Cell Signaling Technology; 1:1,000 dilution), S6-pSer236/236 (2211, rabbit, Cell Signaling Technology; 1:1,000 dilution), S6 (2217, rabbit, Cell Signaling Technology; 1:1,000 dilution), ubiquitin (sc-8017, mouse, Santa Cruz Biotechnology; 1:250 dilution) and V5 (R96025, mouse, Invitrogen; 1:5,000 dilution). All immunoblot experiments consisted of at least three independent replicates.
